Board-Certified and Highly Accomplished Lasik Surgeon Now Treating Patients at Lasikplus Houston
HOUSTON, TX / ACCESSWIRE / June 6, 2024 / LASIK eye surgeon and Ophthalmology Residency Program Director of the San...
News
Lifeskills South Florida Expands Mental Health and Addiction Treatment Services to Orlando, Florida
BRENTWOOD, TN / ACCESSWIRE / June 6, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and...
Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
Company expects Loss from Operations to decrease by over 40% YoY and Margin Improvement by over 10% YoYREDWOOD CITY, CA...
FDA Accepts for Review Treosulfan NDA Resubmission
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 6, 2024) - On Thursday, June 6, 2024, Medexus Pharmaceuticals (TSX: MDP)...
BioHarvest Sciences Announces Record $2 Million Monthly Sales
VINIA Subscription Growth Drives 101% Year-over-Year Increase in May Product Sales Orders; Cumulative Customer Reviews Surpass 5,000Vancouver, British Columbia and...
DirectTrust(R) and Digital Therapeutics Alliance Announce Partnership to Provide Accreditation for Digital Therapeutics Industry
Collaboration to expand existing DirectTrust programs by establishing a new accreditation program for efficacy and data privacy and security for...
Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors
KITCHENER, ON / ACCESSWIRE / June 6, 2024 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) today reports that its wholly-owned...
Moderna’s Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address...
Theralase(R) Successfully Destroys Lung Cancer
TORONTO, ON / ACCESSWIRE / June 6, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical...
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
New research data confirms superiority of TRUFORMA's Bulk Acoustic Wave Sensor technology in diagnosing feline hyperthyroidism ANN ARBOR, MI /...
Safety Shot Partners with Capital Drugs To Launch World’s First Beverage To Reduce Blood Alcohol Content in 300 Pharmacies Across the Country
The First of its Kind Vitamin-Packed, Wellness Beverage Brand Continues to Amplify its In-Store Availability Nationwide JUPITER, FL, June 06,...
Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer
Josep Catllà EVP, Chief Corporate Affairs Officer PARIS, FRANCE, 06 June 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global...
Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System
LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing...
SeaStar Medical Announces 25-for-1 Reverse Stock Split
DENVER, June 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions...
Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
BEDMINSTER, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) is proud to announce the...
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on...
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
Company expects to lock database in June andremains on track to report key outcomes later in July. Pepinemab targets astrocyte...
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
Anthos Therapeutics Announces ~84% of Eligible Patients Have Transitioned to Abelacimab in the AZALEA-TIMI 71 Extension Study of Atrial Fibrillation Patients at a Moderate-to-High Risk of Stroke
75% of patients in the rivaroxaban arm voluntarily switched from the once-daily oral anticoagulant to once-monthly abelacimab Landmark AZALEA-TIMI 71 Study...